Revolutionizing Medical Instruments: 3 Stocks Leveraging GenAI Amid Industry Woes

The medical instrument industry is adapting to the application of generative AI (GenAI), enhancing diagnostics, patient monitoring, and intervention workflows. The global AI in healthcare market is valued at $39.34 billion in 2025 and projected to see a CAGR of 44% through 2034. However, challenges such as high implementation expenses, data breach concerns, and broader macroeconomic pressures weigh on the MedTech sector. Companies like Globus Medical, Tactile Systems Technology, and IRadimed Corp. have adapted well to changing consumer preferences.